Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using average lifetime dose rate for intermittent exposures to carcinogens.

R L Kodell1, D W Gaylor, J J Chen

  • 1Biometry Staff, National Center for Toxicological Research, Jefferson, Arkansas 72079.

Risk Analysis : an Official Publication of the Society for Risk Analysis
|September 1, 1987
PubMed
Summary

Estimating cancer risk using average lifetime carcinogen exposure may overestimate actual risk. However, this method never underestimates risk by more than a factor of k/r, offering a conservative approach.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nonlinearity and thresholds in dose-response relationships for carcinogenicity due to sampling variation, logarithmic dose scaling, or small differences in individual susceptibility.

Toxicology and applied pharmacology·2005
Same author

A mechanistic approach to modelling the risk of liver tumours in mice exposed to fumonisin B1 in the diet.

Food additives and contaminants·2001
Same author

A unified approach to risk characterization.

Inhalation toxicology·2001
Same author

Correlation of blood cholinesterase levels with toxicity of sarin in rats.

Journal of toxicology and environmental health. Part A·2001
Same author

Dose-response trend tests for tumorigenesis adjusted for differences in survival and body weight across doses.

Toxicological sciences : an official journal of the Society of Toxicology·2001
Same author

The use of Haber's law in standard setting and risk assessment.

Toxicology·2000

Area of Science:

  • Toxicology
  • Risk Assessment
  • Carcinogenesis

Background:

  • Assessing long-term health risks from carcinogen exposure is crucial.
  • Current risk assessment models often rely on average dose rates.
  • Understanding the limitations of average dose rate estimations is vital for accurate risk evaluation.

Purpose of the Study:

  • To investigate the accuracy of using average lifetime dose rate for carcinogen exposure risk assessment.
  • To compare theoretical risks from intermittent dosing versus continuous dosing based on average rates.
  • To determine the potential overestimation or underestimation of cancer risk by average dose rate models.

Main Methods:

  • Utilized a theoretical multistage model for carcinogenesis.
  • Compared lifetime excess risk under intermittent dosing with continuous dosing scenarios.

Related Experiment Videos

  • Analyzed risk estimates derived from average lifetime dose rates against true theoretical risks.

    • Main Results:

    • Low-dose risk estimates based on average lifetime dose rates can significantly overestimate true cancer risk, potentially by orders of magnitude.
    • The average dose rate method never underestimates the true risk by more than a factor of k/r.
    • k represents the total stages in the multistage model, and r represents dose-related stages.

    Conclusions:

    • Average lifetime dose rate is not always a precise measure for low-dose carcinogen exposure risk.
    • Risk estimates using average dose rates provide a conservative upper bound, never underestimating the true risk.
    • Further refinement of risk assessment models considering dose rate variability is warranted.